DNALite Therapeutics

Recent Finacing

Seed

Recent Raise

$1.5M

DNAlite Therapeutics is a Berkeley-based preclinical biotechnology company developing gastrointestinal gene therapies that deliver functional genes to intestinal epithelium via a proprietary mucosal-delivery platform for monogenic GI diseases.

Founded 2016

California, United States

1-10

Private

dnalite.com

Highlights

Focus Areas

Biotechnology

Genetics

Health Care

Recent Investors

S

Financials

$1.5M

Total Raised

1

Funding round

6

Investors

Team

Upgrade to view the team

See the team members at DNALite Therapeutics.